In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Therics LLC

Latest From Therics LLC

Integra LifeSciences: Mid-Sized Company in Big Company Clothing

Founded in 1989 Integra avoided the sad fates of its peers in tissue engineering (which went bankrupt) by adopting an acquisition strategy that took it into surgical product markets. Integra has enjoyed a compound annual revenue growth rate of 36% since it first embarked on its acquisition strategy in 1999. Its secret of success has been to consolidate fragmented niche markets into which it can create additional value by selling its internally-developed tissue-engineered products. Now, with six operating divisions covering four surgical specialties with a multiplicity of call points, it looks and acts like a large, diversified medical device company. But it's not-with $650 million in revenues, it's a mid-sized company. Can it now, as a mid-sized company with a complicated business, sustain its high level of growth through a combination of acquisitions and organic growth?

Medical Device Business Strategies


Reprogen is applying molecular biology to the technologically underserved markets of infertility and reproductive medicine. Hormone assays give it a research boost.

BioPharmaceutical Strategy

Biomaterials: Mechanical Engineering Meets Biology

Start-ups developing man-made surrogates for living processes hope to achieve the alchemy of turning base materials into human tissue.

Medical Device Strategy

Reprogenesis Inc.

Tissue Engineering. With three core technologies, Reprogenesis has the ability to build in, paint on or inject cell matrices to support tissue growth in a wide variety of applications. The company will focus on urology, plastic and reconstructive surgery, orthopedics and cardiovascular applications. The company is initially working on an enduring treatment for stress incontinence and vesicoureteral reflux, as well as two technologies for breast reconstruction.

Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Therics Inc.
  • AFBS, Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Therics LLC
  • Senior Management
  • James E Wavle Jr., Pres.
  • Contact Info
  • Therics LLC
    Phone: (609) 514-7200
    115 Campus Drive
    Princeton, NJ 08540